Humanized Mouse
Humanized Mouse - Related Videos
11:44
Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
0 Views •
Cited by 3 •
2016
Here, we present a novel humanized mouse liver model generated in Alb-toxin receptor mediated cell knockout (TRECK)/SCID mice following the transplantation of immature and expandable human hepatic stem cells.
03:06
Developing a Humanized Mouse Model with Human Liver Cells and Immune Cells
0 Views •
2025
This video demonstrates a method for generating a dual humanized mouse model with a human immune system and liver cells. It involves transplanting human liver cells and hematopoietic stem and progenitor cells into a transgenic immunodeficient mouse via intrasplenic injection, leading to engraftment of liver cells and development of human immune cells.
02:26
A Technique to Generate a Human PBMC-Engrafted Humanized Xenograft Mouse Model
0 Views •
2025
This video demonstrates an assay to generate a humanized xenograft mouse model. An immunocompromised mouse is injected with cyclophosphamide to cause immune cell depletion. Patient-derived tumor cells mixed with human peripheral blood mononuclear cells (PBMCs) in a hydrogel are subcutaneously injected into the mouse, forming a tumor with infiltrating T cells.
03:35
A Technique for Human Skin Grafting in a Mouse Model
0 Views •
2025
This video demonstrates a method for grafting human skin onto an immunodeficient mouse with a suppressed neutrophil response. The method involves applying human split-thickness skin to the mouse's graft bed, sealing it, and covering it for recovery. Eventually, the human skin adheres to the mouse's skin, establishing vascularization and circulation, resulting in a successful skin xenograft.
05:36
Constructing a Humanized Mouse Model with Engineered Immunity against HIV
0 Views •
2025
The video demonstrates a technique to generate a humanized mouse model with stem-cell-based engineered immunity against the human immunodeficiency virus (HIV). Human fetal thymus tissue and engineered hematopoietic stem cells (HSCs) are implanted into the kidney capsule of a severely immunocompromised mouse. The HSCs, which express chimeric antigen receptors (CARs) against HIV, are mixed in a gelatinous protein mixture that promotes their co-localization with thymus tissue. Post-procedure, the...
FAQs
Humanized mouse models can be built around different human biological components, including hematopoietic stem cells, immune-cell populations, tissues, or patient-derived tumors. When hematopoietic stem cells are transplanted, they can develop into human immune-cell populations inside the host. This component choice determines whether an experiment emphasizes immune development, tumor biology, or interactions between the two.
The immunodeficient host provides a setting in which transplanted human cells, tissues, immune components, or cancer material can be established for study. This makes it possible to combine human biological elements with a living animal environment rather than examining them only in isolation. In cancer research, that arrangement supports analysis of human tumor behavior alongside human immune responses.
A tumor component supplies the disease context, while human immune components provide a way to examine host-tumor relationships. Together, they allow researchers to study tumor–immune interactions in vivo and to evaluate how immunotherapies act against human cancer cells or patient-derived tumors. The model therefore connects cellular mechanisms with treatment responses in a controlled experimental system.
A typical study begins by selecting the human component needed, such as hematopoietic stem cells or a patient-derived tumor. Researchers then transplant or establish that material in an immunodeficient mouse and allow the relevant human cells or cancer to develop within the host. They can subsequently examine tumor–immune interactions or test a therapy under controlled conditions.
These models can show how human cancers respond to drugs in a living system, while also providing information about treatment effects in the presence of human immune components. This is particularly relevant when the research question concerns immunotherapy, because the experiment can assess interactions between the therapy, the tumor, and human immune-cell populations rather than focusing on cancer cells alone.
Humanized mice provide a preclinical bridge between human cellular biology and controlled animal experiments. Their use can improve the relevance of therapeutic testing by placing human tumors, cancer cells, or immune components in a living host before clinical studies begin. In cancer research, this supports structured investigation of candidate treatments and their effects on human disease models.